Ruby Ramos
Psychiatric/Mental Health · Las Vegas, NVNPI 1518392448
Payments from drug & device makers
Across 61 payments — averaging $43.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$260
- AstraZeneca$227
- Merck$177
- AbbVie$167
- Bayer$162
- Dexcom, Inc.$156
- plus $2K from 16 others
What the payments were for
- Food & beverage$2,655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $260 |
| AstraZeneca | 8 | $227 |
| Merck | 7 | $177 |
| AbbVie | 3 | $167 |
| Bayer | 3 | $162 |
| Dexcom, Inc. | 3 | $156 |
| Otsuka America Pharmaceutical, Inc. | 1 | $128 |
| Alkermes, Inc. | 1 | $125 |
| Braeburn Inc. | 1 | $125 |
| GSK | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Incyte Corporation | 1 | $115 |
| Regeneron Healthcare Solutions, Inc. | 1 | $110 |
| Exact Sciences | 6 | $106 |
| E.r. Squibb & Sons, L.L.C. | 1 | $99 |
| Neurocrine Biosciences, Inc. | 4 | $92 |
| Boehringer Ingelheim | 1 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Lilly USA, LLC | 4 | $59 |
| Lundbeck LLC | 3 | $57 |
| Boston Scientific | 1 | $35 |
| Amgen | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$500
- REXULTI$128
- ARISTADA INITIO$125
- TRELEGY ELLIPTA$125
- Fanapt$125
- BRIXADI$125
- VRAYLAR$125
- DEXCOM G7 GSS (161)$124
- CAPLYTA$120
- MONJUVI$115
- Kerendia$112
- DUPIXENT$110
How this compares
$2,655 in reported general payments places this provider in the 80th percentile of 362 psychiatric/mental health providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 24 | $30,406 |
| LybalviOlanzapine/Samidorphan Malate | 13 | $19,597 |
| Aripiprazole | 126 | $3,865 |
| Atomoxetine Hcl | 21 | $2,893 |
| Lurasidone Hcl | 27 | $1,334 |
| Quetiapine Fumarate | 97 | $1,097 |
| Duloxetine Hcl | 52 | $1,084 |
| Hydroxyzine Hcl | 100 | $947 |
| Zolpidem Tartrate | 25 | $934 |
| Bupropion XlBupropion Hcl | 63 | $918 |
| Sertraline Hcl | 129 | $889 |
| Trazodone Hcl | 165 | $868 |
| Oxcarbazepine | 16 | $862 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $825 |
| Mirtazapine | 52 | $808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $128 | $30,40624 claims |
| Alkermes, Inc.Lybalvi | $125 | $19,59713 claims |
| Lilly USA, LLCOlanzapine | $59 | $40030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 362 psychiatric/mental health providers in Nevada.
Other psychiatric/mental health in Las Vegas
- Michelle GiddingsLas Vegas$131K
- Patrick ApiladoLas Vegas$19K
- Joshua HamiltonLas Vegas$17K
- Sydney EganLas Vegas$14K
- Ma Victoria EscardaLas Vegas$12K
- Carminia SalvacionLas Vegas$12K
- Valentina AkohLas Vegas$12K
- Angela WilsonLas Vegas$11K
- Michael MathisenLas Vegas$10K
- Edina BorosLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.